{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/VNRX/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-14T23:56:55.230Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":12048,"canonical_name":"VOLITIONRX LTD","cik":"0000093314","uei":null,"lei":null,"duns":null,"ticker":"VNRX"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":24},"count":24,"timeline":[{"ts":"2026-09-25","kind":"sec.filing","form_type":"8-K","title":"8-K — VOLITIONRX LTD — 2026-09-25","url_slug":"/sec/cik-0000093314/8-k/0001477932-26-005804","accession_number":"0001477932-26-005804","importance":35},{"ts":"2026-09-15","kind":"sec.filing","form_type":"8-K","title":"8-K — VOLITIONRX LTD — 2026-09-15","url_slug":"/sec/cik-0000093314/8-k/0001477932-26-005620","accession_number":"0001477932-26-005620","importance":35},{"ts":"2026-09-14","kind":"sec.filing","form_type":"8-K","title":"8-K — VOLITIONRX LTD — 2026-09-14","url_slug":"/sec/cik-0000093314/8-k/0001477932-26-005578","accession_number":"0001477932-26-005578","importance":35},{"ts":"2026-09-09","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — VOLITIONRX LTD — 2026-09-09","url_slug":"/sec/cik-0000093314/effect/9999999995-26-002936","accession_number":"9999999995-26-002936","importance":30},{"ts":"2026-09-09","kind":"sec.filing","form_type":"S-3/A","title":"S-3/A — VOLITIONRX LTD — 2026-09-09","url_slug":"/sec/cik-0000093314/s-3-a/0001477932-26-005469","accession_number":"0001477932-26-005469","importance":30},{"ts":"2026-09-08","kind":"sec.filing","form_type":"S-3/A","title":"S-3/A — VOLITIONRX LTD — 2026-09-08","url_slug":"/sec/cik-0000093314/s-3-a/0001477932-26-005458","accession_number":"0001477932-26-005458","importance":30},{"ts":"2026-09-02","kind":"sec.filing","form_type":"8-K","title":"8-K — VOLITIONRX LTD — 2026-09-02","url_slug":"/sec/cik-0000093314/8-k/0001477932-26-005351","accession_number":"0001477932-26-005351","importance":35},{"ts":"2026-09-02","kind":"sec.filing","form_type":"8-K","title":"8-K — VOLITIONRX LTD — 2026-09-02","url_slug":"/sec/cik-0000093314/8-k/0001477932-26-005359","accession_number":"0001477932-26-005359","importance":35},{"ts":"2026-08-28","kind":"sec.filing","form_type":"S-3","title":"S-3 — VOLITIONRX LTD — 2026-08-28","url_slug":"/sec/cik-0000093314/s-3/0001477932-26-005317","accession_number":"0001477932-26-005317","importance":30},{"ts":"2026-08-24","kind":"sec.filing","form_type":"8-K","title":"8-K — VOLITIONRX LTD — 2026-08-24","url_slug":"/sec/cik-0000093314/8-k/0001477932-26-005251","accession_number":"0001477932-26-005251","importance":35},{"ts":"2026-08-21","kind":"sec.filing","form_type":"S-8","title":"S-8 — VOLITIONRX LTD — 2026-08-21","url_slug":"/sec/cik-0000093314/s-8/0001477932-26-005229","accession_number":"0001477932-26-005229","importance":30},{"ts":"2026-08-13","kind":"sec.filing","form_type":"10-Q","title":"10-Q — VOLITIONRX LTD — 2026-08-13","url_slug":"/sec/cik-0000093314/10-q/0001477932-26-004995","accession_number":"0001477932-26-004995","importance":45},{"ts":"2026-08-13","kind":"sec.filing","form_type":"8-K","title":"8-K — VOLITIONRX LTD — 2026-08-13","url_slug":"/sec/cik-0000093314/8-k/0001477932-26-004991","accession_number":"0001477932-26-004991","importance":35},{"ts":"2026-08-07","kind":"sec.filing","form_type":"8-K","title":"8-K — VOLITIONRX LTD — 2026-08-07","url_slug":"/sec/cik-0000093314/8-k/0001477932-26-004778","accession_number":"0001477932-26-004778","importance":35},{"ts":"2026-07-21","kind":"sec.filing","form_type":"8-K","title":"8-K — VOLITIONRX LTD — 2026-07-21","url_slug":"/sec/cik-0000093314/8-k/0001477932-26-004421","accession_number":"0001477932-26-004421","importance":35},{"ts":"2026-07-17","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — VOLITIONRX LTD — 2026-07-17","url_slug":"/sec/cik-0000093314/effect/9999999995-26-002355","accession_number":"9999999995-26-002355","importance":30},{"ts":"2026-07-10","kind":"sec.filing","form_type":"S-3","title":"S-3 — VOLITIONRX LTD — 2026-07-10","url_slug":"/sec/cik-0000093314/s-3/0001477932-26-004265","accession_number":"0001477932-26-004265","importance":30},{"ts":"2026-06-18","kind":"sec.filing","form_type":"8-K","title":"8-K — VOLITIONRX LTD — 2026-06-18","url_slug":"/sec/cik-0000093314/8-k/0001477932-26-003932","accession_number":"0001477932-26-003932","importance":35},{"ts":"2026-06-10","kind":"sec.filing","form_type":"8-K","title":"8-K — VOLITIONRX LTD — 2026-06-10","url_slug":"/sec/cik-0000093314/8-k/0001477932-26-003740","accession_number":"0001477932-26-003740","importance":35},{"ts":"2026-06-09","kind":"sec.filing","form_type":"424B5","title":"424B5 — VOLITIONRX LTD — 2026-06-09","url_slug":"/sec/cik-0000093314/424b5/0001477932-26-003713","accession_number":"0001477932-26-003713","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"424B5","title":"424B5 — VOLITIONRX LTD — 2026-06-05","url_slug":"/sec/cik-0000093314/424b5/0001477932-26-003669","accession_number":"0001477932-26-003669","importance":30},{"ts":"2026-06-02","kind":"sec.filing","form_type":"DEF 14A","title":"DEF 14A — VOLITIONRX LTD — 2026-06-02","url_slug":"/sec/cik-0000093314/def-14a/0001477932-26-003587","accession_number":"0001477932-26-003587","importance":40},{"ts":"2026-05-15","kind":"sec.filing","form_type":"8-K","title":"8-K — VOLITIONRX LTD — 2026-05-15","url_slug":"/sec/cik-0000093314/8-k/0001477932-26-003241","accession_number":"0001477932-26-003241","importance":35},{"ts":"2026-05-13","kind":"sec.filing","form_type":"PRE 14A","title":"PRE 14A — VOLITIONRX LTD — 2026-05-13","url_slug":"/sec/cik-0000093314/pre-14a/0001477932-26-003053","accession_number":"0001477932-26-003053","importance":30}]}